These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity. Delp J; Gutbier S; Cerff M; Zasada C; Niedenführ S; Zhao L; Smirnova L; Hartung T; Borlinghaus H; Schreiber F; Bergemann J; Gätgens J; Beyss M; Azzouzi S; Waldmann T; Kempa S; Nöh K; Leist M Toxicol Appl Pharmacol; 2018 Sep; 354():64-80. PubMed ID: 29278688 [TBL] [Abstract][Full Text] [Related]
3. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity. Li J; Settivari R; LeBaron MJ; Marty MS Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249 [TBL] [Abstract][Full Text] [Related]
4. Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes. Pistollato F; Canovas-Jorda D; Zagoura D; Bal-Price A Neurochem Int; 2017 Sep; 108():457-471. PubMed ID: 28627367 [TBL] [Abstract][Full Text] [Related]
5. Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres are Suitable for Neurotoxicity Screening. Kobolak J; Teglasi A; Bellak T; Janstova Z; Molnar K; Zana M; Bock I; Laszlo L; Dinnyes A Cells; 2020 May; 9(5):. PubMed ID: 32369990 [TBL] [Abstract][Full Text] [Related]
6. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment. Harrill JA; Freudenrich T; Wallace K; Ball K; Shafer TJ; Mundy WR Toxicol Appl Pharmacol; 2018 Sep; 354():24-39. PubMed ID: 29626487 [TBL] [Abstract][Full Text] [Related]
7. Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept. Pistollato F; de Gyves EM; Carpi D; Bopp SK; Nunes C; Worth A; Bal-Price A Environ Health; 2020 Feb; 19(1):23. PubMed ID: 32093744 [TBL] [Abstract][Full Text] [Related]
8. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells. Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558 [TBL] [Abstract][Full Text] [Related]
9. Developmental Neurotoxicity of Fipronil and Rotenone on a Human Neuronal In Vitro Test System. Schmitz A; Dempewolf S; Tan S; Bicker G; Stern M Neurotox Res; 2021 Aug; 39(4):1189-1202. PubMed ID: 33871813 [TBL] [Abstract][Full Text] [Related]
10. Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology. Ohara R; Imamura K; Morii F; Egawa N; Tsukita K; Enami T; Shibukawa R; Mizuno T; Nakagawa M; Inoue H Clin Pharmacol Ther; 2017 Jun; 101(6):754-762. PubMed ID: 27859025 [TBL] [Abstract][Full Text] [Related]
11. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing. Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830 [TBL] [Abstract][Full Text] [Related]
12. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods. Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865 [TBL] [Abstract][Full Text] [Related]
13. Integrating biokinetics and in vitro studies to evaluate developmental neurotoxicity induced by chlorpyrifos in human iPSC-derived neural stem cells undergoing differentiation towards neuronal and glial cells. Di Consiglio E; Pistollato F; Mendoza-De Gyves E; Bal-Price A; Testai E Reprod Toxicol; 2020 Dec; 98():174-188. PubMed ID: 33011216 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells. Zagoura D; Canovas-Jorda D; Pistollato F; Bremer-Hoffmann S; Bal-Price A Neurochem Int; 2017 Jun; 106():62-73. PubMed ID: 27615060 [TBL] [Abstract][Full Text] [Related]
15. Rotenone-induced neurotoxicity in rat brain areas: a study on neuronal and neuronal supportive cells. Swarnkar S; Goswami P; Kamat PK; Patro IK; Singh S; Nath C Neuroscience; 2013 Jan; 230():172-83. PubMed ID: 23098804 [TBL] [Abstract][Full Text] [Related]
16. Development of the Concept for Stem Cell-Based Developmental Neurotoxicity Evaluation. Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J Toxicol Sci; 2018 Sep; 165(1):14-20. PubMed ID: 29982725 [TBL] [Abstract][Full Text] [Related]
17. Oral supplements of inulin during gestation offsets rotenone-induced oxidative impairments and neurotoxicity in maternal and prenatal rat brain. Krishna G; Muralidhara Biomed Pharmacother; 2018 Aug; 104():751-762. PubMed ID: 29807225 [TBL] [Abstract][Full Text] [Related]
18. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures. Vorhees CV; Sprowles JN; Regan SL; Williams MT Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner. Augustyniak J; Lenart J; Zychowicz M; Stepien PP; Buzanska L Biogerontology; 2017 Aug; 18(4):665-677. PubMed ID: 28643190 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). Krug AK; Gutbier S; Zhao L; Pöltl D; Kullmann C; Ivanova V; Förster S; Jagtap S; Meiser J; Leparc G; Schildknecht S; Adam M; Hiller K; Farhan H; Brunner T; Hartung T; Sachinidis A; Leist M Cell Death Dis; 2014 May; 5(5):e1222. PubMed ID: 24810058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]